Welcome to Holoprosencephaly.net This website was created by parents of children with Holoprosencephaly to help others find information, resources and support. We hope you find this information beneficial. Feel free to email us if you would like to contribute information. We appreciate your help and support. Please read our Mission Statement

DDAVP

From Holoprosencephaly

Jump to: navigation, search


DDAVP

Generic Name: Desmopressin

Uses:

DDAVP (Desmopressin) is a modified form of the normal human hormone arginine vasopressin used to prevent and control excessive thirst, urine production and dehydration in patients with central diabetes insipidus.

It may also be prescribed to reduce frequent bedwetting episodes in children and adults with enuresis by decreasing nocturnal urine production.

Forms:

DDAVP (Desmopressin) comes as a nasal spray, a nasal solution to be administered with a rhinal tube, as a pill, and as a solution for subcutaneous or intravenous injection.


Side Effects:

This is an incomplete list of side effects for DDAVP (Desmopressin). For more information about this medication, please consult your physician.

headaches 
facial flushing 
nausea 
upset stomach or stomach cramps  
stuffy or runny nose 
reddening of the skin 

Precautions:

  • Inform your doctor and pharmacist of an allergy to desmopressin or any other drugs.
  • Tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially carbamazepine (Tegretol), chlorpropamide (Diabinese), clofibrate (Atromid-S), demeclocycline (Declomycin), epinephrine, lithium, and vitamins.
  • Tell your doctor if you have or have ever had heart disease, high blood pressure, coronary artery disease, nose or sinus problems or surgery, or cystic fibrosis.
  • Follow your doctor's directions regarding fluid intake. Drinking too much causes water retention (bloating and swelling of the feet, ankles, and lower legs).
  • Store nasal solutions in the refrigerator.
  • Pill form may be crushed and diluted with water for g-tube administration. After dilution, give immediately because medication will adhere to syringe. This could possibly cause a reduction in the amount of the medication administered.
  • Caregivers who administer DDAVP (Desmopressin) should avoid getting the medication on their skin and wash hands immediately after administration to prevent absorption.
  • It may be necessary for the physician to monitor sodium and electrolyte levels frequently to assess for medication effectiveness. Keep all lab and doctor appointments.

For more information about DDAVP (Desmopressin), please consult with your healthcare provider.

[Click here to learn more about Central Diabetes Insipidus]

[Click here to learn more about how the Endocrine System works]